Canadian Journal of Infectious Diseases (Jan 1992)

Comparative Antifungal Activity of Cilofungin (LY121019) against Candida Species, Including Evaluation of Susceptibility Testing Method

  • Abdul H Chagla,
  • John H Hii,
  • Daryl J Hoban,
  • Andrew E Simor,
  • Santiago Ferro,
  • Evelyn Witwicki,
  • Ruby Poon,
  • Donald E Low

DOI
https://doi.org/10.1155/1992/260839
Journal volume & issue
Vol. 3, no. 5
pp. 231 – 234

Abstract

Read online

The in vitro activity of cilofungin against 100 Candida species was compared with 5-flucytosine. amphotericin B and ketoconazole by two laboratories independently and in a blinded fashion using a macrotitre dilution broth method in saam-f medium. Cilofungin showed good in vitro activity against Candida albicans. Candida tropicalis and Candida glabrata (90% minimal inhibitory concentration [MIC] 3.2 μg/mL) but was inactive against other Candida species. When testing the susceptibility of cilofungin, 5-flucytosine and amphotericin B at the two centres, approximately 90% of the Candida strains had MICs differing by fourfold or less. However, when testing susceptibility of ketoconazole, only 51% of the Candida strains had MIC differences fourfold or less. MIC susceptibility testing with cilofungin, 5-flucytosine and amphotericin B in saam-f medium is reproducible.